
Mays Cancer Center led studies of innovative breast cancer drug that recently gained FDA approval
The Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, was the lead site for a study evaluating Phase I and Phase III clinical trials for elacestrant, a treatment for postmenopausal women and adult men with ER+/HER2- advanced or metastatic breast cancer.
READ MORE

Alzheimer’s disease clinical trial seeks 21 area volunteers
A clinical trial conducted at UT Health San Antonio aims to “stomp” out Alzheimer’s disease. Clearing old, damaged “zombie” cells from the brain may be one way to do it.
READ MORE

Treatment for combat-related PTSD advances with method shown to be fast, effective
Study findings out today in JAMA Network Open show an important step forward in treating the psychological injuries of war. Researchers report that treatment for combat-related post-traumatic stress disorder (PTSD), which affects hundreds of thousands of U.S. military personnel and veterans, can be both fast and effective for a majority of patients.
READ MORE